The growing frequency of authorized generics has important implications for the welfare of
prescription drug consumers. Authorized generic entry could affect the timing of generic …

Continuous innovation is one of the pharmaceutical industry's most defining characteristics.
New medications can be crucial for maintaining the quality of human life, and may even …

Americans rely extensively upon prescription medications to maintain health and quality of
life. According to the National Center for Health Statistics, in 2002, at least 1.5 billion drugs …

Background: Literature from the US has shown that brand-name manufacturers do not
compete on price once generic competitors become available. This study was undertaken to …

This paper investigates patterns of industrial dynamics and competition in the
pharmaceutical industry, with particular reference to the consequences of patent expiry in …

This paper examines the role of regulation and competition in generic markets. Generics
offer large potential savings to payers and consumers of pharmaceuticals. Whether the …

Paragraph IV of the Hatch-Waxman Act provides a mechanism for the litigation of
pharmaceutical patent infringement disputes. Many of these cases have been settled with …

This paper demonstrates how, by introducing a generic version of its previously patented
product, a branded firm can influence the equilibrium in the generic segment of the market …

Increasing the adoption of generic drugs has the potential to improve static efficiency in a
health system without harming pharmaceutical innovation. However, very little is known …

Rising healthcare costs, particularly pharmaceutical expenditures, have led to the
implementation of several pharmaceutical pricing regulations and policies throughout the …